Turnstone Biologics
在场
Turnstone Biologics 是一家在股票代码 TSBX (US) 下上市的公司。
高管
查看带有其 13 名主要高管的组织结构图
Turnstone Biologics 搜索最多的简介
- Sammy Farah, President and Chief Executive Officer
- Jerel Davis, Chairman of the Board
- Kanya Rajangam, Director
高管在Turnstone Biologics变化
- William Waddill已作为Director加入公司 (新闻发布的2024四月17号).
创建提醒
跟踪 Turnstone Biologics 的高管变动
健康
Turnstone Biologics 拥有 1,966 家竞争者，其中包括 Siemens Healthineers (德国)、IQVIA (美国(美洲)) 和 Nestlé Health Science (瑞士)。
Popular M&A news in 健康
- Radon Medical Imaging 已收购 Alpha Imaging (公布2024十一月20号).
- TowerBrook Capital Partners 已收购 R1 RCM (公布2024十一月19号).
- Kewaunee Scientific 已收购 Nu Aire (公布2024十一月6号).
健康 行业的其他推荐联系人
消息
Turnstone Biologics 的最新新闻稿
- Turnstone Biologics Announces Strategic Restructuring to Prioritize Portfolio and Extend Financial Runway | Turnstone Biologics
- Turnstone Biologics Corp. Reports Positive Initial Data from Phase 1 Trial of TIDAL-01 in Metastatic Colorectal Cancer | Turnstone Biologics
- Turnstone Biologics Corp. Reports Second Quarter 2024 Financial Results and Provides Recent Business Highlights | Turnstone Biologics
- Turnstone Biologics Corp. Reports First Quarter 2024 Financial Results and Provides Recent Business Highlights | Turnstone Biologics
- Turnstone Biologics to Present at the 2024 Bank of America Securities Health Care Conference | Turnstone Biologics
- Turnstone Biologics Appoints William Waddill to its Board of Directors | Turnstone Biologics
- News Releases | Turnstone Biologics
- Turnstone Biologics Corp. Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Recent Business Highlights | Turnstone Biologics
- Turnstone Biologics to Participate in Upcoming Investor Conferences | Turnstone Biologics
- Turnstone Biologics to Present Preclinical Data for Selected Tumor-Infiltrating Lymphocyte (TIL) Therapy at Society for Immunotherapy of Cancer’s (SITC) 38th Annual Meeting | Turnstone Biologics
- View more press releases Close
通过电子邮件
